$OMDA

Duffy Sean P. sold $509K of OMDA

Duffy Sean P. (Chief Executive Officer) sold 21,572 shares of Omada Health, Inc. (OMDA) at an average of $23.62 ($23.12–$24.27, $0.51M total) across 4 trades on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Duffy Sean P.
Published Sep 3, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 7:12 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Bearish
medium confidence
Mentioned
$OMDA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDABearishLow
01

Why it matters

The disclosed sale adds slight bearish pressure but is unlikely to move the stock significantly.

02

Market read

Primary relevance is to traders monitoring insider activity; limited broader market effect.

03

What to watch

CEO may be diversifying personal assets; the 10b5‑1 plan pre‑arranged.

Relevance 4/10Novelty 4/10Timing: Filed 2026‑09‑03, reflecting a sale on 2026‑09‑01.

Background

Form 4 filing discloses insider transactions required by SEC; provides first public notice of the sale.

Company-level read

Ticker impact

$OMDABearishMedium confidence
Context

CEO Sean P. Duffy sold 21,572 shares for $509,465 via a 10b5‑1 plan on 2026‑09‑01.

Expected impact

Potential short‑term dip of 1‑2% as market digests the sale.

Evidence & confidence

Sale size is modest relative to holdings, but insider sales often trigger sell‑side bias.

Market effects

Minimal impact on digital health sector; similar insider sales have limited ripple.

U.S. market only; no broader regional effect.

Low; the filing is company‑specific.

Counterpoint

The sale could be routine liquidity planning, not a lack of confidence.

Key entities

  • Omada Health, Inc.

    Digital health platform listed on Nasdaq under ticker OMDA.

  • Sean P. Duffy

    Chief Executive Officer of Omada Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch